| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |